TALS
TALARIS THERAPEUTICS INC
$2.72
Earnings Summary
Net Profits | $-14.74Mn |
Highlights
TALARIS THERAPEUTICS INC’s net profit jumped 18.56% since last year same period to $-14.74Mn in the Q2 2023. On a quarterly growth basis, TALARIS THERAPEUTICS INC has generated 29.54% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the TALARIS THERAPEUTICS INC post its latest quarter earnings
EPS Estimate Current Quarter | -0.03 |
EPS Estimate Current Year | -0.03 |
Highlights
TALARIS THERAPEUTICS INC’s earning per share (EPS) estimates for the current quarter stand at -0.03 - a 90.63% jump from last quarter’s estimates.
TALARIS THERAPEUTICS INC’s earning per share (EPS) estimates for the current year stand at -0.03.
Key Ratios
Key ratios of the TALARIS THERAPEUTICS INC post its Q4 2023 earnings
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 3.02 |
Highlights
TALARIS THERAPEUTICS INC’s earning per share (EPS) jumped NaN% since last year same period to 0 in the Q4 2023. This indicates that the TALARIS THERAPEUTICS INC has generated NaN% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
TALARIS THERAPEUTICS INC declared 3.02 dividend per share during the earnings announcement for Q4 2023.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-10 | -0.32 | 0 | 100% |
2023-08-14 | -0.43 | 0 | 100% |
2023-05-15 | -0.55 | 0 | 100% |
2024-03-15 | -0.03 | 0 | 100% |
₹0 US Stocks a/c Opening Fee